We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$314B
AUM Growth
+$16.9B
Cap. Flow
+$2.33B
Cap. Flow %
0.74%
Top 10 Hldgs %
12.02%
Holding
3,572
New
111
Increased
1,840
Reduced
1,366
Closed
91

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$272M
2
CVX icon
Chevron
CVX
+$206M
3
TSLA icon
Tesla
TSLA
+$153M
4
NVDA icon
NVIDIA
NVDA
+$143M
5
PFE icon
Pfizer
PFE
+$131M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$242M
2
FSLR icon
First Solar
FSLR
+$153M
3
WMT icon
Walmart Inc
WMT
+$133M
4
STLD icon
Steel Dynamics
STLD
+$115M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$109M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Financials 15.55%
3 Industrials 13.68%
4 Consumer Discretionary 11.04%
5 Healthcare 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRCA icon
3326
Verrica Pharmaceuticals
VRCA
$90.4M
$97.9K ﹤0.01%
1,697
CMPX icon
3327
Compass Therapeutics
CMPX
$349M
$96.8K ﹤0.01%
+30,450
New +$95.6K
IPSC icon
3328
Century Therapeutics
IPSC
$395M
$96.4K ﹤0.01%
30,491
-8,962
-23% -$28.9K
IMUX icon
3329
Immunic
IMUX
$191M
$96K ﹤0.01%
3,823
+1,036
+37% +$17.4K
BCAB icon
3330
BioAtla
BCAB
$5.61M
$95.8K ﹤0.01%
639
-281
-31% -$48.3K
BYRN icon
3331
Byrna Technologies
BYRN
$103M
$95.8K ﹤0.01%
19,123
TULP
3332
Bloomia Holdings
TULP
$15.6M
$95.8K ﹤0.01%
12,704
TDUP icon
3333
ThredUp
TDUP
$757M
$94.8K ﹤0.01%
38,849
+12,684
+48% +$33.2K
CPSH icon
3334
CPS Technologies
CPSH
$77.3M
$94K ﹤0.01%
33,581
-2
-0% -$6
GANX icon
3335
Gain Therapeutics
GANX
$75.1M
$93.9K ﹤0.01%
20,962
+2,355
+13% +$11.5K
APRN
3336
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$92.7K ﹤0.01%
+15,876
New +$107K
FTHM icon
3337
Fathom Holdings
FTHM
$26.3M
$92.2K ﹤0.01%
+12,912
New +$72.2K
MFIN icon
3338
Medallion Financial
MFIN
$233M
$90.6K ﹤0.01%
11,451
MASS icon
3339
908 Devices
MASS
$313M
$89.9K ﹤0.01%
13,107
-29,410
-69% -$236K
JVA icon
3340
Coffee Holding Co
JVA
$19.4M
$89.1K ﹤0.01%
64,104
-26,234
-29% -$43.6K
RBOT
3341
DELISTED
Vicarious Surgical
RBOT
$88.6K ﹤0.01%
+1,615
New +$103K
FKWL icon
3342
Franklin Wireless
FKWL
$27.2M
$87.6K ﹤0.01%
23,495
ONCY
3343
Oncolytics Biotech
ONCY
$89.9M
$87.1K ﹤0.01%
33,485
ZEV
3344
DELISTED
Lightning eMotors, Inc.
ZEV
$86.3K ﹤0.01%
+23,978
New +$109K
BDTX icon
3345
Black Diamond Therapeutics
BDTX
$98.6M
$86.3K ﹤0.01%
17,087
-8,833
-34% -$18K
ORKA
3346
Oruka Therapeutics
ORKA
$5.9B
$86.3K ﹤0.01%
3,542
CRMD icon
3347
CorMedix
CRMD
$588M
$85.6K ﹤0.01%
21,601
PMCB icon
3348
PharmaCyte Biotech
PMCB
$6.44M
$83.8K ﹤0.01%
29,303
DMTK
3349
DELISTED
DermTech, Inc. Common Stock
DMTK
$83K ﹤0.01%
+31,932
New +$95.5K
ADAP
3350
DELISTED
Adaptimmune Therapeutics
ADAP
$82K ﹤0.01%
+88,580
New +$106K

Similar funds

Dimensional Fund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

  • Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
  • Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
  • Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
  • Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
  • Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
  • Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
  • Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.